In a report released today, Jack Slevin from Jefferies maintained a Hold rating on Agilon Health, with a price target of $1.10.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Jack Slevin has given his Hold rating due to a combination of factors affecting Agilon Health. The company is currently facing significant challenges, including leadership changes and ongoing issues with prior-period development, which have impacted their financial performance. The recent departure of the CEO and the interim leadership by Ron Williams highlight a sense of urgency to address these problems.
Despite these challenges, Agilon Health has a cash balance that provides some runway to navigate these issues, but the margin for error is narrowing. The company’s valuation and cash situation suggest that management might need to explore aggressive options to stabilize performance. Slevin remains cautious and recommends holding the stock until a clearer strategic direction is established, with a price target set at $1.10.